SELLAS Life Sciences Group, Inc. (SLS) stock
SLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$19.15+11.68 (+156.36%)
Close on Nov 17, 2026Market cap $3.87BP/E –Yield –
SELLAS Life Sciences operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
SELLAS Life Sciences's operating cash flow for the twelve months ending Jun 30, 2026 was -$28.42M. For fiscal 2025 it was -$28.39M. The highest annual figure on record is -$10.26M in fiscal 2010.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$28.39M | – |
| FY2024 | Dec 31, 2024 | -$35.40M | – |
| FY2023 | Dec 31, 2023 | -$31.41M | – |
| FY2022 | Dec 31, 2022 | -$23.81M | – |
| FY2021 | Dec 31, 2021 | -$26.02M | – |
| FY2020 | Dec 31, 2020 | -$10.42M | – |
| FY2019 | Dec 31, 2019 | -$17.64M | – |
| FY2018 | Dec 31, 2018 | -$30.42M | – |
| FY2017 | Dec 31, 2017 | -$10.99M | – |
| FY2016 | Dec 31, 2016 | -$11.85M | – |
| FY2015 | Dec 31, 2015 | -$48.16M | – |
| FY2014 | Dec 31, 2014 | -$42.87M | – |
| FY2013 | Dec 31, 2013 | -$28.93M | – |
| FY2012 | Dec 31, 2012 | -$20.97M | – |
| FY2011 | Dec 31, 2011 | -$14.67M | – |
| FY2010 | Dec 31, 2010 | -$10.26M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$7.59M | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.85M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.92M | – |
| Q3 FY2025 | Sep 30, 2025 | -$7.07M | – |
| Q2 FY2025 | Jun 30, 2025 | -$7.33M | – |
| Q1 FY2025 | Mar 31, 2025 | -$9.07M | – |
| Q4 FY2024 | Dec 31, 2024 | -$7.15M | – |
| Q3 FY2024 | Sep 30, 2024 | -$7.81M | – |
| Q2 FY2024 | Jun 30, 2024 | -$9.68M | – |
| Q1 FY2024 | Mar 31, 2024 | -$10.76M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.83M | – |
| Q3 FY2023 | Sep 30, 2023 | -$6.89M | – |
| Q2 FY2023 | Jun 30, 2023 | -$7.57M | – |
| Q1 FY2023 | Mar 31, 2023 | -$12.13M | – |
| Q4 FY2022 | Dec 31, 2022 | -$5.15M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.75M | – |
| Q2 FY2022 | Jun 30, 2022 | -$5.76M | – |
| Q1 FY2022 | Mar 31, 2022 | -$7.15M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.98M | -245.3% |
| Q3 FY2021 | Sep 30, 2021 | -$5.88M | – |
| Q2 FY2021 | Jun 30, 2021 | -$4.90M | – |
| Q1 FY2021 | Mar 31, 2021 | -$10.27M | – |
| Q4 FY2020 | Dec 31, 2020 | $3.42M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.63M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.38M | – |
| Q1 FY2020 | Mar 31, 2020 | -$6.83M | – |
| Q4 FY2019 | Dec 31, 2019 | -$4.18M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.82M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.66M | – |
| Q1 FY2019 | Mar 31, 2019 | -$4.99M | – |
| Q4 FY2018 | Dec 31, 2018 | -$4.56M | – |
| Q3 FY2018 | Sep 30, 2018 | -$14.17M | – |
| Q2 FY2018 | Jun 30, 2018 | -$6.30M | – |
| Q1 FY2018 | Mar 31, 2018 | -$5.40M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.74M | -106.9% |
| Q3 FY2017 | Sep 30, 2017 | -$2.40M | – |
| Q2 FY2017 | Jun 30, 2017 | -$3.05M | – |
| Q1 FY2017 | Mar 31, 2017 | -$3.80M | – |
| Q4 FY2016 | Dec 31, 2016 | $25.07M | – |
| Q3 FY2016 | Sep 30, 2016 | -$12.21M | – |
See a number that looks wrong?